<table id="_Refid_067b8260-210f-49f8-8fd2-25ffbb235" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 13. Established and Other Potentially Significant Drug Interactions</caption>
<col width="43%"></col>
<col width="25%"></col>
<col width="47%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Concomitant Drug </paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>Effect on Concentration of Lamotrigine or Concomitant Drug</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>Clinical Comment</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Estrogen-containing oral contraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>Decreased lamotrigine levels approximately 50%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule "></td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ levonorgestrel</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decrease in levonorgestrel component by 19%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Carbamazepine (CBZ) and CBZ epoxide</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>Addition of carbamazepine decreases lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule "></td>
<td stylecode="Rrule Botrule ">
<paragraph>? CBZ epoxide</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>May increase CBZ epoxide levels </paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Phenobarbital/primidone</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Phenytoin (PHT)</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Rifampin</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased lamotrigine AUC approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule ">
<paragraph>Valproate</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>↑ lamotrigine</paragraph>
</td>
<td stylecode="Rrule ">
<paragraph>Increased lamotrigine concentrations slightly more than 2-fold.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule "></td>
<td stylecode="Rrule Botrule ">
<paragraph>? valproate</paragraph>
</td>
<td stylecode="Rrule Botrule ">
<paragraph>Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients. </paragraph>
</td>
</tr>
</tbody>
</table>